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The Genetic Relationship Between Alcohol Consumption
and Aspects of Problem Drinking in an Ascertained Sample
EmmaC. Johnson , Celine L. St. Pierre, Jacquelyn L. Meyers, Fazil Aliev, Vivia V.
McCutcheon, Dongbing Lai, Danielle M. Dick , Alison M. Goate, John Kramer , Samuel
Kuperman, John I. Nurnberger Jr., Marc A. Schuckit , Bernice Porjesz, Howard J.
Edenberg , Kathleen K. Bucholz, and Arpana Agrawal
Background: Genomewide association studies (GWAS) have begun to identify loci related to alco-
hol consumption, but little is known about whether this genetic propensity overlaps with speciﬁc indices
of problem drinking in ascertained samples.
Methods: In 6,731 European Americans who had been exposed to alcohol, we examined whether
polygenic risk scores (PRS) from a GWAS of weekly alcohol consumption in the UK Biobank pre-
dicted variance in 6 alcohol-related phenotypes: alcohol use, maximum drinks within 24 hours
(MAXD), total score on the Self-Rating of the Eﬀects of Ethanol Questionnaire (SRE-T), DSM-IV
alcohol dependence (DSM4AD), DSM-5 alcohol use disorder symptom counts (DSM5AUDSX), and
reduction/cessation of problematic drinking. We also examined the extent to which an single nucleotide
polymorphism (rs1229984) in ADH1B, which is strongly associated with both alcohol consumption
and dependence, contributed to the polygenic association with these phenotypes and whether PRS
interacted with sex, age, or family history of alcoholism to predict alcohol-related outcomes. We per-
formed mixed-eﬀect regression analyses, with family membership and recruitment site included as ran-
dom eﬀects, as well as survival modeling of age of onset of DSM4AD.
Results: PRS for alcohol consumption signiﬁcantly predicted variance in 5 of the 6 outcomes: alco-
hol use (Dmarginal R2 = 1.39%, D area under the curve [AUC] = 0.011), DSM4AD (Dmarginal
R2 = 0.56%; DAUC = 0.003), DSM5AUDSX (Dmarginal R2 = 0.49%), MAXD (Dmarginal
R2 = 0.31%), and SRE-T (Dmarginal R2 = 0.22%). PRS were also associated with onset of DSM4AD
(hazard ratio = 1.11, p = 2.08e5). The inclusion of rs1229984 attenuated the eﬀects of the alcohol
consumption PRS, particularly for DSM4AD and DSM5AUDSX, but the PRS continued to exert an
independent eﬀect for all 5 alcohol measures (Dmarginal R2 after controlling for ADH1B = 0.14 to
1.22%). Interactions between PRS and sex, age, or family history were nonsigniﬁcant.
Conclusions: Genetic propensity for typical alcohol consumption was associated with alcohol use
and was also associated with 4 of the additional 5 outcomes, though the variance explained in this sam-
ple was modest. Future GWAS that focus on the multifaceted nature of AUD, which goes beyond con-
sumption, might reveal additional information regarding the polygenic underpinnings of problem
drinking.
Key Words: Alcohol Dependence, Alcohol Consumption, Polygenic Risk, ADH1B.
ALCOHOL CONSUMPTION RANGES from infre-quent intake of alcoholic beverages, through more fre-
quent and heavy episodic drinking (e.g., bingeing), to
drinking at problematic levels that are potentially indicative
of alcohol use disorders (AUDs). While there is considerable
debate surrounding the putative beneﬁts of moderate
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drinking (Stockwell et al., 2016; Wood et al., 2018), exces-
sive alcohol consumption has been unequivocally identiﬁed
as one of the top 10 contributors to worldwide morbidity
and mortality (World Health Organization, 2014). Excessive
alcohol consumption can escalate to AUD diagnosis when
accompanied by other psychological, behavioral, and physi-
cal symptoms, such as loss of control over drinking, toler-
ance, withdrawal, and persistent drinking despite health
problems (Wise and Koob, 2014). It is estimated that AUD-
attributable costs approximate 1% of the gross domestic
product of developed nations (Rehm et al., 2009).
Both alcohol consumption and AUD (as well as other
indices of problematic drinking, e.g., the problem subscale of
the Alcohol Use Disorders Identiﬁcation Test [AUDIT-P];
Sanchez-Roige et al., 2017) are heritable. Twin studies sug-
gest that additive genetic factors contribute to 40 to 70% of
the variance in alcohol consumption and AUD (Heath and
Martin, 1994; Prescott and Kendler, 1999; Verhulst et al.,
2015). The degree to which there is overlap in the genetic fac-
tors contributing to alcohol consumption versus AUD is less
clear from twin data (Agrawal et al., 2011; Dick et al., 2011;
Grant et al., 2009; Kendler et al., 2010), but recent genome-
wide association studies (GWAS) have estimated this overlap
using linkage disequilibrium score regression (LDSC; Bulik-
Sullivan et al., 2015). Based on GWAS of both alcohol con-
sumption (N = 112, 117; Clarke et al., 2017) and DSM-IV
alcohol dependence (DSM4AD; N = 14,904 cases and
37,944 controls; Walters et al., 2018), common variants
explain, in aggregate, between 9 and 13% of the variance in
these phenotypes (i.e., single nucleotide polymorphisms
[SNPs] heritability) and the estimated genetic correlation
between them ranges from rg = 0.37 to 0.70 (Walters et al.,
2018).
As the correlation between consumption measures and
dependence is derived from composite phenotypes (e.g., alco-
hol dependence diagnosis using structured interviews or clini-
cian reports, consumption via self-reports) and in
heterogeneous samples, further work is needed to pinpoint
which speciﬁc aspects of drinking (e.g., lifetime alcohol use
vs. alcohol dependence diagnosis) are most genetically corre-
lated with self-reported levels of alcohol consumption. To
study particular features of problem drinking, ascertained
samples that are enriched for liability to alcohol dependence
may provide increased power through larger sample sizes as
well as detailed phenotyping. However, it is likely that sev-
eral factors might moderate the extent to which genetic liabil-
ity for alcohol consumption in a speciﬁc discovery
population, such as the older volunteer cohort that com-
prises the UK Biobank, is associated with problem drinking
in an independent sample. One possibility is that genetic
overlap might be more pronounced in a similar age-group as
that comprising the discovery GWAS, possibly due to
cohort-speciﬁc genetic and environmental inﬂuences. Other
moderators might include sex, cultural eﬀects, and access to
alcohol, as well as family history of alcohol problems. For
instance, family history has been shown in other studies to
accentuate the impact of genetic vulnerability on psychiatri-
cally relevant outcomes (e.g., Agerbo et al., 2015).
Beyond genetic correlations from LDSC, polygenic risk
scores (PRS) oﬀer an alternative approach for demonstrating
genetic overlap between 2 traits (e.g., alcohol consumption
and AUD). PRS represent the additive eﬀects of independent
SNPs that are weighted by their eﬀect sizes from a “discov-
ery” GWAS (International Schizophrenia Consortium,
2009). With this approach, every individual in the indepen-
dent “target” sample is assigned a score that indexes their
estimated genetic propensity to the behavior studied in the
discovery GWAS. The phenotype of interest in the target
sample is then regressed on the polygenic score, and the
strength of this association is assessed using R2 or other mea-
sures of predictor eﬃcacy (e.g., area under the curve [AUC]).
Although the PRS incorporates additional SNPs beyond
those meeting the stringent genomewide signiﬁcance thresh-
old, PRS typically explain a very small percentage (usually
<10%) of the variance in the target sample phenotype (Dud-
bridge, 2013; Wray et al., 2014). How much variance PRS
explain is dependent upon the SNP heritability of the pheno-
type, the size of both the discovery GWAS and the target
sample, the selection thresholds for SNPs included in the
PRS, and the methods used for weighting the eﬀect sizes
(Dudbridge, 2013). The extent to which a PRS derived from
a GWAS of alcohol consumption is associated with aspects
of problem drinking is, therefore, an estimate of their genetic
commonality, although causal processes can also be repre-
sented (Swerdlow et al., 2016).
To date, the most robust genetic signals identiﬁed for both
alcohol consumption and dependence have been within
ADH1B (across multiple ancestries; Bierut et al., 2012;
Clarke et al., 2017; Kranzler et al., 2019; Luczak et al.,
2006; Sanchez-Roige et al., 2018; Walters et al., 2018).
Recent GWAS of alcohol consumption (Jorgenson et al.,
2017; Liu et al., 2019; Schumann et al., 2011, 2016) have
implicated loci in AUTS2, KLB, GCKR, and other genes;
however, evidence for their involvement in the genetics of
alcohol dependence remains limited (Sanchez-Roige et al.,
2018), although a recent preprint implicatedGCKR in a large
GWAS of AUD (Kranzler et al., 2019). The protective allele
of rs1229984, the missense SNP within ADH1B that aﬀects
the conversion of ethanol (EtOH) to acetaldehyde, exerts
one of the largest single-variant eﬀects on a polygenic trait,
with up to a 3-fold decrease in risk for alcohol dependence
(Edenberg, 2007; Edenberg and McClintick, 2018). Thus,
studies that examine the polygenic overlap between con-
sumption and dependence should account for the role of
ADH1B in aggregated genomic propensity.
In this study, we use a large (N = 6,731), deeply pheno-
typed target sample of European Americans who reported
ever drinking alcohol (and enriched for those with alcohol
dependence) and a very large (N = 112,117) discovery
GWAS in a European-only volunteer cohort (the UK Bio-
bank) to examine the genetic overlap between alcohol con-
sumption and nonproblem as well as problematic drinking
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behaviors. Our target sample consists of individuals from the
Collaborative Study on the Genetics of Alcoholism (COGA)
who have been assessed 1 or more times using an instrument
speciﬁcally designed to evaluate risk for substance use and
common psychiatric disorders. We utilized a PRS approach
to examine the polygenic overlap between self-reported alco-
hol consumption in the UK Biobank volunteer cohort and
several aspects of drinking in COGA. We aimed to leverage
the unique strengths of both samples in this study to ask: (i)
whether a polygenic score for alcohol consumption (average
intake per week) from a population-based cohort predicts a
range of drinking milestones in a sample that is enriched for
familial risk for alcohol problems, (ii) whether any associa-
tion between the PRS and drinking milestones is moderated
by age, sex, or family history of AUDs, and (iii) whether the
PRS is associated with aspects of drinking above and beyond
the eﬀect of the strongest signal for AUD, rs1229984 in
ADH1B.
MATERIALS ANDMETHODS
Sample
The COGA currently consists of 12,145 individuals with
GWAS data. The goal of COGA is to elucidate the genetic
underpinnings of AUDs and problem drinking across the
lifespan. The study is described in detail elsewhere (Begleiter
et al., 1995; Bucholz et al., 2017). Brieﬂy, probands were
identiﬁed through primarily inpatient alcohol treatment pro-
grams at 7 U.S. sites. Probands and their family members
were invited to participate if they had a suﬃciently large fam-
ily (usually >3 sibs with parents available) with 2 or more
members in the COGA catchment area. Control families (2
parents and 3 or more oﬀspring over the age of 14) were also
selected from a variety of sources (e.g., dental clinics, driver
license registries). The Institutional Review Boards at all sites
approved this study, and written consent was obtained from
all participants. As the PRS were derived from a sample of
Europeans, only individuals identiﬁed as part of the Euro-
pean American subsample of COGA, determined using
genomic data, were included in the analyses reported here
(N = 7,645). To avoid confounding by individuals at high
genetic risk who elected not to drink due to personal (e.g.,
religious, cultural, health) reasons, we also excluded individ-
uals reporting no lifetime use of alcohol (N = 336). We also
excluded those aged 12 to 19 (N = 578) as they may not be
past the period of maximal risk for onset of alcohol use and
problems, yielding a ﬁnal analysisN = 6,731.
Genotyping
Genotyping for the COGA European American partici-
pants was performed using the Illumina 1M, Illumina
OmniExpress, and Illumina 2.5M (Illumina, San Diego,
CA), and Smokescreen (BioRealm, Walnut, CA) arrays.
Array type was included as a covariate in all analyses. A
pruned set of 47,000 variants that were genotyped on all plat-
forms, had minor allele frequencies (MAFs) >10% in the
combined samples, Hardy–Weinberg equilibrium (HWE) p-
values > 0.001, and missing rates <2%, and were not in link-
age disequilibrium (LD, deﬁned as R2 < 0.5) were used to
assess reported pedigree structure using identity-by-descent
calculations in PLINK (https://www.cog-genomics.org/
plink/1.9/general_usage#cite) (Purcell et al., 2007). Family
structures were altered as needed, and SNP genotypes were
tested for Mendelian inconsistencies with the revised family
structure (O’Connell and Weeks, 1998). Genotype inconsis-
tencies were set to missing. Imputation was to 1,000 Gen-
omes (European (EUR) and African ancestries (AFR),
Phase 3, b37, October 2014; build hg19) using SHAPEIT2
(https://mathgen.stats.ox.ac.uk/genetics_software/shapeit/
shapeit.html#home) (Delaneau et al., 2012) and then Mini-
mac3 (Das et al., 2016). Only nonpalindromic variants with
missing rates <5%, minor allele frequency (MAF) >3%, and
HWE p-values > 0.0001 were used for imputation. Imputed
SNPs with information scores <0.30 or individual genotype
probability scores <0.90 were excluded. For the ﬁnal dataset
for PRS construction, palindromic SNPs (A/T or C/G),
monomorphic SNPs, SNPs that did not pass HWE
(p < 1e6), and SNPs with a MAF less than 0.005 were
excluded. In total, 6,881,872 SNPs passed quality control
and data cleaning thresholds and were available for analysis.
Genotypes that did not pass quality control prior to and
upon imputation were excluded from PRS construction.
Measures
All COGA participants were interviewed at least once
using a version of the Semi-Structured Assessment for the
Genetics of Alcoholism (Bucholz et al., 1994; Hesselbrock
et al., 1999). For these analyses, an individual’s interview
with the highest lifetime report for each measure was used.
Measures included the following:
Alcohol Use. Drinking at least 1 drink a month for 6 or
more consecutive months at any point in the lifetime (yes/
no).
Maximum Drinks (MAXD). The maximum number of
drinks ever consumed in a single 24-hour period (range = 1
to 100; values >100 (N = 32) were constrained to 100). To
correct for skew, this variable was transformed by taking the
natural logarithm of (MAXD).
Total Score for the Self-Rating of the Eﬀects of EtOH
(SRE-T). The SRE-T score was derived from a self-report
instrument administered to a smaller subset of COGA partic-
ipants (N = 4,296) and assesses the participant’s response to
4 items that address the number of drinks required for the
participant to feel the eﬀects of alcohol, feel dizzy, or begin
to slur in speech, to stumble, or to fall asleep. Scores across 3
time points (ﬁrst 5 times the participant used alcohol, last
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3 months, and period of heaviest drinking) are averaged to
create the total (SRE-T) score (Schuckit et al., 1997), win-
sorized at 2 standard deviations from the mean, and fur-
ther transformed using the square root of the value to
correct for skew.
DSM4AD. We elected to use DSM-IV (American Psy-
chiatric Association, 2000) lifetime criteria for alcohol depen-
dence, the endorsement of 3 or more of 7 dependence criteria
that clustered within a single 12-month period, because it
represents a more severe form of the diagnosis than the
DSM-5. Age of onset of alcohol dependence (DSM-IV) was
used in survival analyses, with those who had not met criteria
for DSM4AD censored at their age at the last interview.
DSM-5 Alcohol Use Disorder Symptom Count
(DSM5AUDSX). We elected to use DSM-5 criteria for
the quantitative index of AUD severity as it captures addi-
tional aspects of the disorder beyond DSM-IV dependence,
thus providing a broader scale of liability. The lifetime
endorsement of the 11 DSM-5 (American Psychiatric Associ-
ation, 2013) criteria for AUD, summed at the interview with
maximum number of symptoms, was used.
Reduction/Cessation of Problematic Drinking. An unor-
dered categorical measure was created to represent 3 groups:
(i) those who did not meet criteria for DSM-5 AUD during
their lifetime; (ii) individuals who had a lifetime history of
DSM-5 AUD and were current problematic drinkers due to
an active AUD diagnosis in the past 12 months or were
high-risk drinkers (deﬁned as men: ≥5 drinks/d or ≥15 drinks
in 1 week; women: ≥4 drinks/d or ≥8 in 1 week; National
Institute on Alcohol Abuse and Alcoholism, 2004); and (iii)
those who had a lifetime history of AUD but had reduced/
ceased their drinking and either did not report any AUD cri-
teria (except craving), or were not high-risk drinkers, or were
abstinent from alcohol, all in the past 12 months (McCutch-
eon et al., 2017; Schuckit et al., 2018). A comparison of
Group A against either Group B or Group C contrasts pres-
ence or absence of a lifetime diagnosis of DSM-5 AUD,
while the comparison of Group B and Group C stratiﬁes
those with a lifetime diagnosis into high-risk drinkers, includ-
ing those with active AUD, and low-risk drinkers who may
also be in abstinent remission.
Covariates included sex, participant’s age at their last
interview, birth cohort (dummy variables representing birth
years prior to 1930, 1930 to 1949, 1950 to 1969, and 1970
and after), the ﬁrst 3 ancestral principal components, array
type, recruitment site, and the total number of interviews
with the participant.
Family History. A binary measure representing whether
at least one of the biological parents of the respondent had a
history of DSM-5 AUD was used. Various sources of infor-
mation were used to derive family history (e.g., parental
interview, respondent report; see Bucholz et al., 2017;
McCutcheon et al., 2017, for details). Of the analytic sample,
1,656 individuals did not have a report on family history,
and 485 individuals had a missing report on 1 parent while
the other parent was conﬁrmed to be family history negative.
Thus, family history was not included as a covariate in all
analyses, and for analyses including family history (e.g.,
PRS*family history), the sample size was smaller
(N = 5,075).
Statistical Analysis
Construction of PRS. Eﬀect sizes and eﬀect alleles were
derived from a GWAS of N = 112,117 unrelated European-
ancestry individuals in the UK Biobank (Clarke et al., 2017).
Participants were asked about their current drinking status
(never, previous, current, prefer not to say) and their average
weekly and monthly consumption of a variety of alcoholic
beverages (e.g., red wine, white wine, beer, spirits). An over-
all measure of average alcohol intake per week was derived
from these measures. Age and weight were then regressed
onto alcohol consumption in units per week in males and
females separately, and the residuals from these regressions
were then pooled (males + females) to form the alcohol con-
sumption phenotype of interest. A GWAS was conducted
with 12,489,782 quality-controlled SNPs and UK Biobank
(UKB) assessment center, genotyping batch, and 15 principal
components included as additional covariates. In COGA,
after removing palindromic/ambiguous SNPs from the sum-
mary statistics, PRS were coded for every individual by mul-
tiplying an individual’s number of eﬀect alleles at a
particular SNP by that SNP’s eﬀect size (beta) from the dis-
covery GWAS, then averaging across SNPs to create 1 score
per person. Clumping was done using the European subset
of the 1,000 Genomes Phase 3 sample (1000 Genomes Pro-
ject Consortium, 2015) as an external LD reference panel,
using a 500 kb physical distance and an LD threshold of
r2 ≥ 0.25. Scores representing eﬀect sizes with increasingly
lenient thresholds of statistical signiﬁcance in the discovery
GWAS were constructed (pT < 0.0001, pT < 0.001,
pT < 0.01, pT < 0.05, pT < 0.10, pT < 0.20, pT < 0.30,
pT < 0.40, pT < 0.50). Scores were standardized before statis-
tical analysis.
Data Analysis. All analyses were conducted in R (R Core
Team, 2017). First, mixed-eﬀect regressions were used to
examine whether alcohol consumption PRS predicted (i)
alcohol use, (ii) MAXD, (iii) DSM5AUDSX, (iv) DSM4AD,
(v) SRE-T, and (vi) cessation/reduction of problem drinking,
and to determine which PRS threshold (i.e., pT) was most
predictive of the drinking measure based on the p-value and
R2. For the cessation/reduction measure, groups were con-
trasted with each other using binary comparisons (e.g.,
Group B vs. Group C). All regressions controlled for the
covariates mentioned above as ﬁxed eﬀects, while the family
identiﬁer and recruitment site were included in the models as
random eﬀects (family nested within site). To assess model ﬁt
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and the relative amount of variance explained by the PRS,
we used the “MuMIn” (https://cran.r-project.org/web/packa
ges/MuMIn/index.html) package in R to calculate both mar-
ginal and conditional R2 for each mixed model (Barton,
2012; Nakagawa and Schielzeth, 2012). We use the marginal
R2 to select the most predictive pT. The proportion of vari-
ance attributable to the PRS (Dmarginal R2) was estimated
as the diﬀerence between the marginal R2 (i.e., Dmarginal) of
the model that included covariates and the PRS and the
model with covariates alone (i.e., marginal R2[full
model]  marginal R2[model without PRS]). Further, Cox
proportional hazards survival analyses for onset of
DSM4AD were conducted using the survival and survminer
packages in R (https://rpkgs.datanovia.com/survminer/inde
x.html) (Kassambara et al., 2017; Therneau and Lumley,
2015) with the same covariates as above. Violations of the
proportional hazards assumption for the PRS were tested
using scaled Schoenfeld residuals. For graphical depiction of
cumulative survival curves, quartiles of PRS were computed
and hazard ratios were estimated across those categories,
with adjustment for covariates. Family membership and
recruitment site were included in the survival models using
the “cluster()” function, which produces a robust estimate of
standard errors that accounts for potential clustering on
those 2 variables (Therneau and Grambsch, 2013; Therneau
and Lumley, 2015).
Next, we selected the most predictive p-value threshold
(pT) to test for PRS-by-age, PRS-by-sex, and PRS-by-family
history interactions. Each interaction was tested in an inde-
pendent model with all other cross-term covariates included
(Keller, 2014). Finally, since the strongest and most robustly
validated genetic signal for alcohol consumption and depen-
dence is rs1229984 in ADH1B, we examined the extent to
which including rs1229984 genotype as a covariate attenu-
ated the variance explained by the PRS, for traits where alco-
hol consumption PRS were signiﬁcantly predictive. The
potential attenuation was computed by contrasting a model
that included covariates and rs1229984 (coded in the direc-
tion of the eﬀect allele, i.e., those homozygous for the protec-
tive allele were coded as 2) with a model that included those
terms as well as the PRS (i.e., null model: Pheno-
type ~ rs1229984 + covariates vs. full model: Pheno-
type ~ PRS + rs1229984 + covariates).
Two additional analytic considerations were made. First,
there have been increasing concerns regarding the potential
oversampling for susceptibility to smoking in a subcompo-
nent of the UK Biobank (the UK BiLEVE sample; see
Munafo et al., 2017). To examine this possibility, alcohol
consumption PRS were also regressed on a measure of maxi-
mum cigarettes smoked per day (however, any observed
association might also reﬂect pleiotropy, given the genetic
correlation between smoking and drinking). Second, even
though pseudo-R2 is the most widely accepted index of pre-
dictive utility for PRS analyses of categorical outcomes, met-
rics such as AUC may provide a more conservative and
precise estimate of their predictive capabilities for binary
traits (Wray et al., 2013). Thus, we supplemented a subset of
our analyses with estimates of AUC. Youden’s J index (sensi-
tivity + speciﬁcity  1) was used to generate the optimal
cut-point in PRS for prediction of any signiﬁcantly associ-
ated dichotomous traits (Youden, 1950).
The number of independent multiple tests across the 6 pri-
mary phenotypes (alcohol use, MAXD, SRE-T, DSM4AD,
DSM5AUDSX, and reduction/cessation) was estimated by
identifying the degree of phenotypic correlation across the
measures of drinking using spectral decomposition of the
data in matSpD (Nyholt, 2004). Five independent tests were
estimated (Veﬀ = 4.82). Thus, for the ﬁrst set of analyses,
where PRS (including 9 p-value thresholds) predicted mea-
sures of drinking, we corrected for 45 tests (9 PRS thresholds
for each of the 5 independent phenotypic tests), for a Bonfer-
roni-corrected p-value of 0.05/45 = 1.1e03. For follow-up
analyses (e.g., adjustment for rs1229984), where only a single
PRS at one p-value threshold was used, a less stringent cor-
rection of 0.05/5 = 0.01 was implemented.
RESULTS
Characteristics of the COGA sample (N = 6,731) are pro-
vided in Table 1. As expected, nearly 90% of the sample
reported a lifetime history of alcohol use (at least once a
month for at least 6 consecutive months). The prevalence of
problem drinking (including DSM4AD and DSM5AUD)
Table 1. Characteristics of 6,731 Participants of European Descent More
Than 20 Years Old in the COGA
Overall
(n = 6,731)
Female (%)
Born before 1930 17.6%
Born 1930 to 1949 41.7%
Born in 1950 to 1969 36.1%
Born in 1970–now 4.6%
Age at last interview (mean [SD]) 38.697 (14.189)
Family history positivea (%) (N = 5,075) 71.1%
Number of interviews (mean [SD]) 2.246 (1.528)
Alcohol use 89.9%
DSM-IV alcohol dependence (DSM4AD) 33.8%
Age at onset of alcohol dependence (mean [SD]) 33.3 (15.1)
Alcohol dependent with active AUD or high-risk
drinking
63.9%
Reduction/cessationb (N = 6,718)
Active DSM-5 AUD or high-riskc drinkers 33.4%
Nonactive DSM-5 AUD who are currently abstinent or
currently low-risk drinkers
16.0%
No lifetime DSM-5 AUD diagnosis—and low-risk
drinkers
50.5%
Maximum drinks in 24 hrs (MAXD; mean [SD]) 18.9 (16.4)
Self-Rating of the Effects of Ethanol (SRE-T) score
(N = 4,337)
2.21 (0.61)
DSM-5 Alcohol use disorder symptom count
(DSM5AUDSX; mean [SD])
3.07 (3.47)
aFamily history positive: either or both parents have history of lifetime
AUD.
bReflects past-12-month report at final interview.
cHigh risk defined as ≥5 drinks/d or ≥15 drinks in 1 week for men and ≥4
drinks/d or ≥8 in 1 week for women.
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was relatively high as well. For instance, the lifetime preva-
lence of DSM4AD was 33.8%, while 19.0, 11.1, and 22.5%
endorsed 2 to 3, 4 to 5, and 6 or more DSM5AUD lifetime
criteria, respectively.
As shown in Table 2, the alcohol consumption PRS pre-
dicted alcohol use, DSM4AD, and DSM5AUDSX at all pT,
even after correction for multiple testing. It predicted the
greatest variance in alcohol use (Dmarginal R2 = 0.0139;
PRS pT < 0.2), followed by DSM4AD (Dmarginal
R2 = 0.0056; PRS pT < 0.01). DSM5AUDSX was also sig-
niﬁcantly associated with the PRS (Dmarginal R2 = 0.0049;
PRS pT < 0.5). MAXD was associated with the PRS at
thresholds pT < 0.5 to 0.001 (maximum Dmarginal
R2 = 0.0031), while SRE-T scores were only associated with
the alcohol consumption PRS at pT < 0.1 (Dmarginal
R2 = 0.0022). The results pattern for reduction/cessation of
problem drinking suggests that the PRS were only associated
with the diﬀerence between those with no lifetime DSM-5
AUD (Group A) versus the group with active DSM-5 AUD
and/or high-risk drinking (Group B) (PRS pT < 0.10: odds
ratio [OR] = 1.21, 95% conﬁdence interval (CI) = 1.14 to
1.27, p = 1.29e8). The PRS was not signiﬁcantly associated
with the comparisons between those with no lifetime
DSM5AUD versus lifetime DSM5AUD but now being low-
risk/abstinent (Group C; OR = 1.09, 95% CI = 1.01 to 1.18,
p = 0.028) or between those with active DSM5AUD/high-
risk drinking and those who were low-risk/abstinent
(OR = 0.94, 95% CI = 0.86 to 1.02, p = 0.105). Because of
Table 2. The Percent Variance for Alcohol Consumption and ProblemDrinking Indices in COGAExplained by PRS
N SNPs Alcohol use MAXD
Self-rating of the
effects of EtOH
(SRE-T)
DSM-5 AUD
symptom count
(DSM5AUDSX)
DSM-IV alcohol
dependence
(DSM4AD)
Reduction/
cessation of
problem drinkinga
(no lifetime AUD vs.
active AUD/high-
risk drinking only)
pT < 0.5 313,399 1.11
* 0.26* 0.18 0.49* (p = 4.54e-10) 0.57* 0.69*
pT < 0.4 268,741 1.13
* 0.25* 0.18 0.47* 0.52* 0.61*
pT < 0.3 217,799 1.28
* 0.25* 0.18 0.46* 0.47* 0.67*
pT < 0.2 159,282 1.39
* (p = 3.22e-8) 0.26* 0.17 0.48* 0.49* 0.75*
pT < 0.1 91,805 1.27
* 0.31* (p = 1.29e-7) 0.22* (p = 7.01e-4) 0.44* 0.59* 0.83* (p = 1029e-8)
pT < 0.05 51,951 1.35
* 0.27* 0.18 0.36* 0.48* 0.72*
pT < 0.01 13,626 1.04
* 0.29* 0.16 0.37* 0.56* (p = 1.55e-7) 0.45*
pT < 0.001 2,048 0.48
* 0.18* 0.17 0.22* 0.36* 0.32*
pT < 0.0001 349 0.58
* 0.08 0.10 0.14* 0.29* 0.25
Percent variance explained was determined via Dmarginal R2. The most predictive threshold (based on p-value) for each outcome is bolded. Alcohol
use was defined as having had at least 1 drink per month for at least 6 consecutive months. The SRE-T is the SRE score averaged across 3 time points
(first 5 times the participant used alcohol, last 3 months, and period of heaviest drinking). There were 3 pairwise comparisons for the reduction/cessation
outcome: comparing (i) those with no lifetime AUD, (ii) those with lifetime AUD and current symptoms or no symptoms but high-risk drinking, and (iii) those
who stopped drinking altogether (were abstinent for the past 12 months) or who were low-risk drinking; only the comparison between those with no life-
time AUD and those with lifetime AUD and/or high-risk drinking is shown here. AUD, alcohol use disorder; COGA, Collaborative Study on the Genetics of
Alcoholism; MAXD, maximum drinks; PRS, polygenic risk scores; SNPs, single nucleotide polymorphisms.
*Denotes significance at Bonferroni-corrected p-value of 0.05/45 = 1.1e3.
aComputed using pairwise comparisons of logistic regression models; reported DR2 is for the comparison between those with no lifetime AUD versus
those with lifetime AUD and current symptoms or no symptoms but high-risk drinking; other comparisons (e.g., between those with active AUD and/or
high-risk drinking vs. those with lifetime AUD who are currently abstinent or low-risk drinkers) were nonsignificant.
Table 3. Association Between PRS Derived for Alcohol Consumption and Problem Drinking Indices, Adjusting for rs1229984 (ADH1B)
DSM-IV alcohol
dependence
(DSM4AD)
DSM-5 AUD symptom
count (DSM5AUDSX) Alcohol use SRE-T MAXD
Most predictive PRS pT < 0.01 pT < 0.5 pT < 0.2 pT < 0.1 pT < 0.1
Dmarginal R2 for PRS (%) 0.562 0.490 1.389 0.217 0.308
Dmarginal R2 for ADH1B (%) 1.19 0.527 0.549 0.403 0.347
Beta (SE) for ADH1B 0.951 (0.159),
p = 2.25e09
0.967 (0.165),
p = 5.31e09
0.674 (0.159),
p = 2.15e05
0.165 (0.035),
p = 2.65e06
0.204 (0.040),
p = 3.10e07
Dmarginal R2 for ADH1B,
adjusting for PRS (%)
1.13 0.486 0.489 0.380 0.319
Dmarginal R2 for PRS, adjusting for
ADH1B (%)
0.420 0.395 1.22 0.141 0.247
Beta (SE) for PRS, after adjusting for
ADH1B
0.144 (0.032),
p = 6.31e06
0.221 (0.040),
p = 2.65e08
0.235 (0.046),
p = 3.90e07
0.023 (0.008),
p = 0.006
0.045 (0.010),
p = 1.81e06
AUD, alcohol use disorder; MAXD, maximum drinks; PRS, polygenic risk scores.
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this limited association with the PRS, the reduction/cessation
measure was not carried forward into the conditional (con-
trolling for rs1229984) follow-up analysis. DSM4AD and
DSM5AUDSX were strongly correlated with maximum
cigarettes smoked (p < 0.001), but alcohol consumption
PRS were not predictive of maximum cigarettes smoked
(N = 5,436, p = 0.67).
Even though PRS pT < 0.01 was associated with
DSM4AD at a < 1.1e3, the diﬀerence in AUC attributable
to the addition of the PRS was modest (AUC-covari-
ates = 0.710; AUC-covariates + PRS = 0.713; equality test
v2 = 6.62, p = 0.01). Results for alcohol use were far stron-
ger: The AUC in a model where PRS alone predicted alcohol
use was 0.57. Even in comparison to the model with covari-
ates alone (AUC = 0.688), addition of PRS resulted in a sta-
tistically signiﬁcant increase in prediction of alcohol use
(AUC = 0.70; equality test v2 = 9.36, p = 0.0022). Youden’s
J was 0.11 (sensitivity = 0.49, speciﬁcity = 0.62), and a PRS
cut-point of 0.0524 was determined to maximize classiﬁca-
tion, but at a weak AUC of 0.56.
The correlations between the PRS and rs1229984 ranged
from 0.15 to0.05. As shown in Table 3, the variance pre-
dicted by the PRS was partially independent of the inclusion
of rs1229984 in ADH1B. There was a signiﬁcant association
between rs1229984 genotype and alcohol use, DSM4AD,
DSM5AUDSX, MAXD, and SRE-T with rs1229984 pre-
dicting 0.34 to 1.19% of the variance in these drinking mea-
sures. After including rs1229984 genotype as a covariate, the
alcohol consumption PRS continued to predict 0.14 to
1.22% of the variance across the drinking measures. In par-
ticular, rs1229984 genotype had the least inﬂuence on alcohol
use, for which the PRS predicted more variance than the
ADH1B genotype (Dmarginal R2 for ADH1B conditional on
PRS = 0.49%; Dmarginal R2 for PRS conditional on
ADH1B = 1.22%).
Within the survival analysis framework, alcohol consump-
tion PRS (pT < 0.01) were associated with a 1.11 [95%
CI = 1.06 to 1.16, p = 2.08e5] hazards of onset of
DSM4AD, even after adjustment for covariates. There was
no evidence for violation of the proportional hazards
assumption. As shown in Fig. 1 (panel A), individuals with
scores in the lowest quartile were least likely to have met cri-
teria for DSM4AD, with survival probabilities being higher
particularly in those aged 35 and older. Adjustment for
rs1229984, which was strongly associated with decreased risk
of onset of DSM4AD (hazard ratio [HR] = 0.48, 95%
CI = 0.37 to 0.63, p = 7.85e08), had little inﬂuence on the
eﬀect of the overall PRS (HR = 1.09, 95% CI = 1.04 to
1.14, p = 2.86e4).
As expected, sex was strongly associated with all aspects of
problem drinking, including DSM4AD and DSM5AUDSX
(p < 2e16; higher likelihood of problem drinking in males).
Family history was positively associated with all drinking
measures except for alcohol use. Age at last interview was
associated with DSM4AD, DSM5AUDSX, and the reduc-
tion/cessation comparison of those with no lifetime AUD
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(Group A) versus those with lifetime AUD and current
symptoms or no symptoms but high-risk drinking (Group
B), even after accounting for birth cohort eﬀects. Mean PRS
did not diﬀer as a function of sex, age, or family history
(p > 0.1). Interactions between the PRS and sex, age at ﬁnal
interview, and family history were nonsigniﬁcant (p > 0.05),
suggesting uniformity of eﬀect sizes across these groups
(Table 4).
DISCUSSION
The GWAS summary statistics used here (Clarke et al.,
2017) are derived from simple questionnaire-based items
related to typical consumption of various types of alcoholic
beverages (e.g., beer, wine, liquor). Such assessments are
amenable to collection in very large samples such as the UK
Biobank, and meta-analyses of GWAS data for such simple
alcohol measures have succeeded in locus discovery (Clarke
et al., 2017; Jorgenson et al., 2017; Liu et al., 2019; Schu-
mann et al., 2016). It is unclear whether all loci identiﬁed
using these indices of typical drinking will overlap with the
genetic variants that contribute to other drinking milestones
and features, including alcohol dependence. Not only does
alcohol dependence involve high levels of alcohol consump-
tion, but it also includes a signiﬁcant loss of control over
drinking, drinking to ameliorate negative mood states,
impairment of interpersonal and vocational functioning, and
a general transition from impulsive to compulsive use (Koob
and Kreek, 2007). One prior GWAS noted that the genetic
correlation between alcohol consumption and dependence
was modest and variable (Walters et al., 2018). Another
recent study that draws on the UK Biobank data suggests
that indices of recent problem drinking (e.g., failed to do
what was expected because of drinking) were genetically cor-
related with psychopathology, while indices of more moder-
ate alcohol consumption were not (and in some instances
were negatively correlated) (Sanchez-Roige et al., 2018). The
present study provides evidence that the aggregated genetic
eﬀects related to typical alcohol consumption in an older vol-
unteer cohort do predict signiﬁcant (albeit very modest) pro-
portions of variance in various indices of drinking, including
problem drinking, over and above the eﬀects of rs1229984.
However, in the current analyses the strongest associations
occurred with a broad measure of alcohol use. This is not
entirely surprising, since the alcohol consumption PRS is
based on typical weekly intake, which itself is partly derived
from frequency of drinking.
Five ﬁndings are noteworthy. First, alcohol consumption
PRS predicted a very modest proportion of variance
(<0.6%) in DSM-IV alcohol dependence (DSM4AD) and
DSM-5 AUD symptomatology (DSM5AUDSX). This esti-
mate is relatively consistent with the extent to which PRS
tend to explain cross-trait variance. For instance, a recent
study examined the extent to which alcohol consumption
PRS (derived from a smaller meta-analysis; Schumann et al.,
2016) predicted recent drinking (alcohol consumption and
AUDIT scores) in a sample of 5,456 participants aged 18 to
83 years (Mies et al., 2018); at the most predictive thresh-
olds, alcohol consumption PRS predicted 0.11% of the vari-
ance in recent drinking. A similar analysis of the Avon
Longitudinal Study of Parents and Children found that an
89-SNP risk score (derived from literature searches) pre-
dicted up to 0.66% of the variance in typical alcohol con-
sumption (Taylor et al., 2016). Despite this consistency, the
AUC estimate suggests that the consumption PRS minimally
(but signiﬁcantly) improves classiﬁcation for DSM4AD.
These ﬁndings point to the extremely high polygenicity
underlying alcohol intake and problem drinking such that
even the aggregated eﬀects of SNPs explain only modest
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Fig. 1. Survival curves representing the relationship between age of
onset of alcohol dependence and quartiles of polygenic risk for alcohol
consumption. Panel (A): survival curves adjusted for sex, age at last inter-
view, birth cohort, array type, total number of interviews, and ancestral
principal components; panel (B): adjusted for covariates in panel (A) as
well as for rs1229984 in ADH1B.
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proportions of variance. These ﬁndings also suggest that
there may be only modest genetic overlap between the range
of normal alcohol consumption and problematic drinking
phenotypes.
Second, despite being a quantitative index of alcohol con-
sumption, maximum number of drinks consumed in a single
24-hour period (MAXD) was less eﬀectively predicted by the
alcohol consumption PRS (R2 ≤ 0.31%). MAXD is geneti-
cally correlated with problem drinking (Agrawal et al., 2009;
Grant et al., 2009) and correlates well with quantitative
indices of tolerance (Kendler et al., 2012; Schuckit et al.,
2008). The lower prediction might be related to MAXD
being potentially inﬂuenced by a single episode of heavy
drinking and, thus, not indicative of either typical or prob-
lem drinking. Likewise, total scores on the subjective ratings
of EtOH (SRE-T) were not predicted by alcohol consump-
tion PRS. SRE-T is an index of alcohol sensitivity and has
primarily been studied as a predisposing factor for and pre-
dictor of later problem drinking (Schuckit and Smith, 2013).
Individuals with higher SRE-T scores demonstrate lower
level of response to alcohol, potentially via dampening of
neural and physiological pathways in response to alcohol
(Schuckit, 2018; Schuckit et al., 2008). There are currently
no published GWAS of SRE-T, although a meta-analysis of
a related but etiologically distinct trait representing subjec-
tive ratings of EtOH during the ﬁrst 5 times that alcohol was
consumed (SRE-5) did not ﬁnd loci previously associated
with alcohol consumption or dependence to be related to it
(Edwards et al., 2018). Thus, even though SRE is heritable
(Kalu et al., 2012) and related to alcohol consumption, its
genetic underpinnings may be quite diﬀerent from those
related to alcohol intake.
A third notable observation is that the alcohol consump-
tion PRS explained the most variance for alcohol use
(R2 ≤ 1.39%), which represents drinking at least once a
month for 6 consecutive months at some point during the
lifetime and is ubiquitously endorsed in this sample (89.9%);
this is likely also common in the UK Biobank sample. In
fact, the addition of the PRS signiﬁcantly improved the
AUC for alcohol use, compared to a model of covariates
only. It is likely that alcohol consumption in the UK Bio-
bank represents normative patterns of drinking and does not
suﬃciently index problem drinking. Thus, in COGA, PRS
derived from such an index of normative alcohol consump-
tion was most closely related to an equally heterogeneous
measure of drinking that included normative (and problem)
drinkers. We were unable to examine typical alcohol con-
sumption as it was not assessed in COGA in a similar man-
ner as UK Biobank. Nonetheless, our results suggest that in
this high-risk sample, PRS from large-scale GWAS of alco-
hol consumption were more strongly associated with propen-
sity to alcohol use than with measures of problem drinking
or disorder.
Fourth, we found little evidence for shared genetic overlap
between weekly alcohol consumption and reduction/cessa-
tion of problematic drinking. Prior studies have identiﬁed
candidate variants related to treatment-dependent remission
(e.g., Karpyak et al., 2014), and emerging evidence suggests
high sibling concordance for abstinent remission (McCutch-
eon et al., 2017), suggesting heritable inﬂuences on the tran-
sition from active AUD to low-risk drinking and abstinence.
However, while PRS distinguished those without a lifetime
history of DSM-5 AUD from those with an active diagnosis
or high-risk drinking, they were unrelated to low-risk drink-
ing or abstinence in those with a lifetime history of DSM-5
AUD. This could be partially due to a lack of power: Only
16% of the individuals were in the category of low-risk
drinking and abstinence. This ﬁnding could also suggest that
even though there is polygenic overlap between alcohol con-
sumption and severity of AUD (e.g., DSM5AUDSX), and
individuals who successfully reduce their problem drinking
might have a less severe form of the disorder, the genetic
propensity that extends beyond severity and speciﬁcally pre-
dicts cessation is distinct. One might speculate that genetic
inﬂuences on remission relate less to genetic liability to alco-
hol intake and more to aspects of socioeconomic status (e.g.,
Trim et al., 2013), personality characteristics, and other
comorbid psychiatric disorders (Lopez-Quintero et al.,
2011). Future studies should further explore the heritability
of cessation and its coheritability with other drinking mea-
sures.
Fifth, the addition of rs1229984 in the models attenuated
the eﬀect of the PRS, although only modestly for alcohol
use. While rs1229984 exerts one of the strongest eﬀect sizes
observed for psychiatric and behavioral traits (Edenberg and
McClintick, 2018), other loci related to alcohol dependence
are expected to have noticeably more modest eﬀects (Walters
et al., 2018). In our analyses, the conditional eﬀect of
rs1229984 (i.e., R2 for rs1229984 when including PRS in the
model) was greater for DSM4AD and DSM5AUDSX (ex-
plaining 0.49 to 1.13% of the variance) than the conditional
eﬀect of the PRS after adjusting for rs1229984 (0.40 to
0.42% of variance explained). In fact, the addition of PRS to
the model had negligible impact on the variance in
DSM4AD and DSM5AUDSX already explained by
rs1229984, highlighting this variant’s robust eﬀect on prob-
lem drinking. In contrast, rs1229984 did not substantially
reduce the variance in alcohol use associated with the PRS;
rather, the alcohol consumption PRS explained a greater
percent of the variance in alcohol use (1.22%) than
rs1229984 genotype (0.49%). This suggests that, despite
being an aggregate polygenic index of variants with small
individual eﬀect sizes, the alcohol consumption PRS are
superior predictors of alcohol use compared to rs1229984
alone.
One prior study suggested the polygenic prediction is max-
imized when the discovery and target cohorts have similar
demographic characteristics and ascertainment strategies
(Savage et al., 2018). Thus, it is also possible that the vari-
ance associated with the PRS is greater in the subset of
COGA that is demographically matched to the UK Biobank
participants (e.g., older age). However, age did not appear to
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moderate the association between the PRS and alcohol-re-
lated outcomes in the current study, nor was there support
for absence of proportionality of hazards in the survival
model, suggesting homogeneity of eﬀects across age. Relat-
edly, even though family history was a strong predictor of
problem drinking, we found no evidence that it moderated
the eﬀect of the PRS in our sample. This might be due to the
partially high-risk nature of the COGA sample. Despite dif-
ferences between the characteristics of the discovery sample
and COGA, we detected appreciable variance in alcohol use.
Some limitations of this sample are also noteworthy. First,
we restricted our analyses here to individuals of European
American descent because the discovery GWAS was limited
to individuals of European ancestry, and cross-ancestral pre-
dictions have several limitations (Martin et al., 2017). Sec-
ond, despite being fairly large and predominantly
ascertained for families with many alcohol-dependent indi-
viduals, the COGA sample size may still be underpowered to
detect the very modest percentages of variance explained by
common SNPs for alcohol-related traits (Bogdan et al.,
2018; Clarke et al., 2017; Gratten et al., 2014; Sanchez-
Roige et al., 2017; Walters et al., 2018). In particular,
although certain types of interaction (e.g., crossover eﬀects)
do not necessitate signiﬁcant main eﬀects, we were likely
underpowered to test such interactions with PRS where a
main eﬀect of PRS was undetectable.
While large-scale population-based studies, such as the
UKBiobank, are valuable in their potential to identify multi-
ple risk loci for easily collectible phenotypes, such as alcohol
consumption, and contribute to the development of well-
powered PRS, they may not adequately capture the genetic
factors that contribute to problem drinking, which itself is a
multifaceted phenotype. Until there are similarly large-scale
GWAS conducted in samples ascertained for problem drink-
ing, the amount of genetic overlap between alcohol con-
sumption and problematic drinking behaviors remains
unclear.
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